- Home
- YI vs PTHL Comparison
YI vs PTHL Comparison
Compare YI & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- PTHL
- Stock Information
- Founded
- YI 2010
- PTHL 1998
- Country
- YI China
- PTHL China
- Employees
- YI N/A
- PTHL N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- PTHL
- Sector
- YI Consumer Staples
- PTHL
- Exchange
- YI Nasdaq
- PTHL Nasdaq
- Market Cap
- YI 71.1M
- PTHL 60.5M
- IPO Year
- YI N/A
- PTHL 2024
- Fundamental
- Price
- YI $0.43
- PTHL $3.84
- Analyst Decision
- YI
- PTHL
- Analyst Count
- YI 0
- PTHL 0
- Target Price
- YI N/A
- PTHL N/A
- AVG Volume (30 Days)
- YI 392.6K
- PTHL 40.7K
- Earning Date
- YI 11-27-2024
- PTHL 02-11-2025
- Dividend Yield
- YI N/A
- PTHL N/A
- EPS Growth
- YI N/A
- PTHL N/A
- EPS
- YI N/A
- PTHL N/A
- Revenue
- YI $2,090,255,896.00
- PTHL $572,291.00
- Revenue This Year
- YI $61.85
- PTHL N/A
- Revenue Next Year
- YI N/A
- PTHL N/A
- P/E Ratio
- YI N/A
- PTHL N/A
- Revenue Growth
- YI N/A
- PTHL 2.32
- 52 Week Low
- YI $0.41
- PTHL $3.32
- 52 Week High
- YI $1.60
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- YI 30.18
- PTHL N/A
- Support Level
- YI $0.41
- PTHL N/A
- Resistance Level
- YI $0.54
- PTHL N/A
- Average True Range (ATR)
- YI 0.07
- PTHL 0.00
- MACD
- YI -0.02
- PTHL 0.00
- Stochastic Oscillator
- YI 4.31
- PTHL 0.00
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.